AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Bostom, AG Shemin, D Gohh, RY Beaulieu, AJ Bagley, P Massy, ZA Jacques, PF Dworkin, L Selhub, J
Citation: Ag. Bostom et al., Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients, KIDNEY INT, 59, 2001, pp. S246-S252

Authors: Yango, A Shemin, D Hsu, N Jacques, PF Dworkin, L Selhub, J Bostom, AG
Citation: A. Yango et al., L-folinic acid versus folic acid for the treatment of hyperhomocysteinemiain hemodialysis patients Rapid Communication, KIDNEY INT, 59(1), 2001, pp. 324-327

Authors: Bakris, GL Williams, M Dworkin, L Elliott, WJ Epstein, M Toto, R Tuttle, K Douglas, J Hsueh, W Sowers, J
Citation: Gl. Bakris et al., Preserving renal function in adults with hypertension and diabetes: A consensus approach, AM J KIDNEY, 36(3), 2000, pp. 646-661

Authors: Bostom, AG Shemin, D Gohh, RY Beaulieu, AJ Jacques, PF Dworkin, L Selhub, J
Citation: Ag. Bostom et al., Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients, TRANSPLANT, 69(10), 2000, pp. 2128-2131

Authors: Bostom, AG Shemin, D Bagley, P Massy, ZA Zanabli, A Christopher, K Spiegel, P Jacques, PF Dworkin, L Selhub, J
Citation: Ag. Bostom et al., Controlled comparison of 1-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients (vol 101, pg2829, 2000), CIRCULATION, 102(5), 2000, pp. 598-598

Authors: Bostom, AG Shemin, D Bagley, P Massy, ZA Zanabli, A Christopher, K Spiegel, P Jacques, PF Dworkin, L Selhub, J
Citation: Ag. Bostom et al., Controlled comparison of l-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients, CIRCULATION, 101(24), 2000, pp. 2829-2832

Authors: Smith, AE Sherman, ME Scott, DR Tabbara, SO Dworkin, L Olson, J Thompson, J Faser, C Snell, J Schiffman, M
Citation: Ae. Smith et al., Review of the Bethesda System atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance smears, CANC CYTOP, 90(4), 2000, pp. 201-206

Authors: Shemin, D Lapane, KL Bausserman, L Kanaan, E Kahn, S Dworkin, L Bostom, AG
Citation: D. Shemin et al., Plasma total homocysteine and hemodialysis access thrombosis: A prospective study, J AM S NEPH, 10(5), 1999, pp. 1095-1099

Authors: Bostom, AG Gohh, RY Bausserman, L Hakas, D Jacques, PF Selhub, J Dworkin, L Rosenberg, IH
Citation: Ag. Bostom et al., Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine, J AM S NEPH, 10(1), 1999, pp. 164-166

Authors: Beaulieu, AJ Lapane, KL Gohh, RY Selhub, J Monaco, AP Dworkin, L Rosenberg, IH Bostom, AG
Citation: Aj. Beaulieu et al., Short-term reproducibility of total homocysteine determinations in stable renal transplant recipients, TRANSPLAN P, 31(5), 1999, pp. 2121-2123

Authors: Bostom, AG Gohh, RY Beulieu, AJ Han, H Jacques, PF Selhub, J Dworkin, L Rosenberg, IH
Citation: Ag. Bostom et al., Determinants of fasting plasma total homocysteine levels among chronic stable renal transplant recipients, TRANSPLANT, 68(2), 1999, pp. 257-261

Authors: Bostom, AG Gohh, RY Liaugaudas, G Beaulieu, AJ Han, H Jacques, PF Dworkin, L Rosenberg, IH Selhub, J
Citation: Ag. Bostom et al., Prevalence of mild fasting hyperhomocysteinemia in renal transplant versuscoronary artery disease patients after fortification of cereal grain flourwith folic acid, ATHEROSCLER, 145(1), 1999, pp. 221-224
Risultati: 1-12 |